Published in Eur Heart J on June 01, 2002
Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J (2006) 1.69
Socioeconomic status, Medicaid coverage, clinical comorbidity, and rehospitalization or death after an incident heart failure hospitalization: Atherosclerosis Risk in Communities cohort (1987 to 2004). Circ Heart Fail (2011) 1.64
Palliative care for heart failure. BMJ (2002) 1.57
Event-free survival in adults with heart failure who engage in self-care management. Heart Lung (2010) 1.30
Heart failure in patients with preserved and deteriorated left ventricular ejection fraction. Heart (2005) 1.29
Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993-2001. Heart (2003) 1.26
A propensity-matched study of outcomes of chronic heart failure (HF) in younger and older adults. Arch Gerontol Geriatr (2008) 1.18
The heart failure epidemic. Int J Environ Res Public Health (2010) 1.07
The effectiveness of chronic care management for heart failure: meta-regression analyses to explain the heterogeneity in outcomes. Health Serv Res (2012) 1.07
Cognitive impairment in heart failure. Cardiol Res Pract (2012) 1.03
A cluster randomized controlled trial of a clinical pathway for hospital treatment of heart failure: study design and population. BMC Health Serv Res (2007) 0.98
The Chinese version of the Pediatric Quality of Life Inventory™ (PedsQL™) Family Impact Module: cross-cultural adaptation and psychometric evaluation. Health Qual Life Outcomes (2011) 0.87
Adverse drug events and associated factors in heart failure therapy among the very elderly. Can Geriatr J (2011) 0.83
Hyponatremia and Worsening Sodium Levels Are Associated With Long-Term Outcome in Patients Hospitalized for Acute Heart Failure. J Am Heart Assoc (2016) 0.82
Intraclass correlation coefficients for cluster randomized trials in care pathways and usual care: hospital treatment for heart failure. BMC Health Serv Res (2014) 0.82
Relationship between recommended chronic heart failure treatments and mortality over 8 years in real-world conditions: a pharmacoepidemiological study. Eur J Clin Pharmacol (2012) 0.81
Reducing hospitalizations for heart failure. Eur Heart J (2002) 0.81
Psychometric properties of the Symptom Status Questionnaire-Heart Failure. J Cardiovasc Nurs (2015) 0.80
Utilisation of medications recommended for chronic heart failure and the relationship with annual hospitalisation duration in patients over 75 years of age. A pharmacoepidemiological study. Eur J Clin Pharmacol (2005) 0.79
Effects of care pathways on the in-hospital treatment of heart failure: a systematic review. BMC Cardiovasc Disord (2012) 0.79
New pacing technologies for heart failure. BMJ (2003) 0.79
Heart failure patients' perceptions on nutrition and dietary adherence. Eur J Cardiovasc Nurs (2009) 0.79
Nuclear cardiology and heart failure. Eur J Nucl Med Mol Imaging (2009) 0.78
Provision of palliative care for chronic heart failure inpatients: how much do we need? BMC Palliat Care (2009) 0.77
Heart 'omics' in AGEing (HOMAGE): design, research objectives and characteristics of the common database. J Biomed Res (2014) 0.77
Impact of socio-economic status on the hospital readmission of Congestive Heart Failure patients: a prospective cohort study. Int J Health Policy Manag (2014) 0.77
A Retrospective Study of the Treatment Outcome of Drug Therapies used in Heart Failure Patients with Associated Co-morbidities in a Tertiary Care Hospital. J Clin Diagn Res (2016) 0.75
Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure. Heart (2016) 0.75
Cardiorenal Anemia Syndrome and Survival among Heart Failure Patients in Tanzania: A Prospective Cohort Study. BMC Cardiovasc Disord (2017) 0.75
Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring--further insights from SOLVD. Can J Cardiol (2008) 0.75
Myocardial Viability: From Proof of Concept to Clinical Practice. Cardiol Res Pract (2016) 0.75
New information about resynchronisation. Neth Heart J (2003) 0.75
Cost-utility analysis of percutaneous mitral valve repair in inoperable patients with functional mitral regurgitation in German settings. BMC Cardiovasc Disord (2015) 0.75
Predicting Inpatient Readmission and Outpatient Admission in Elderly: A Population-Based Cohort Study. Medicine (Baltimore) (2016) 0.75
Clinical effects of an optimised care program with telehealth in heart failure patients in a community hospital in the Netherlands. Neth Heart J (2015) 0.75
N-terminal brain natriuretic peptide and subsequent hospital admission for worsening heart failure. Heart (2005) 0.75
Precipitant profile of acute heart failure: experience of a tertiary level cardiac centre in Sri Lanka. Heart Asia (2013) 0.75
Analyzing Dynamic Changes of Laboratory Indexes in Patients with Acute Heart Failure Based on Retrospective Study. Biomed Res Int (2016) 0.75
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ (1994) 11.85
The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet (2002) 10.52
Detecting and describing heterogeneity in meta-analysis. Stat Med (1998) 8.44
Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet (1986) 6.51
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet (1997) 6.48
Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol (1987) 6.20
Assessing possible hazards of reducing serum cholesterol. BMJ (1994) 5.61
Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet (2000) 5.61
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. Lancet (2000) 5.42
Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med (2000) 4.81
Incidence and aetiology of heart failure; a population-based study. Eur Heart J (1999) 4.56
Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation (2003) 4.48
The epidemiology of heart failure. Eur Heart J (1997) 4.31
Does breathing other people's tobacco smoke cause lung cancer? Br Med J (Clin Res Ed) (1986) 4.06
Seasonal variation in arterial blood pressure. Br Med J (Clin Res Ed) (1982) 3.82
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Analysis and interpretation of cost data in randomised controlled trials: review of published studies. BMJ (1998) 3.71
Natural course of peripartum cardiomyopathy. Circulation (1971) 3.60
Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet (1993) 3.56
Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J (2001) 3.49
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ (2004) 3.39
Wasting as independent risk factor for mortality in chronic heart failure. Lancet (1997) 3.37
Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet (1991) 3.29
Haemostatic function and cardiovascular death: early results of a prospective study. Lancet (1980) 3.25
trans isomers of oleic and linoleic acids in adipose tissue and sudden cardiac death. Lancet (1995) 3.12
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation (1999) 3.06
Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet (1999) 3.01
Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol (1995) 2.89
Prevalence of heart failure in three general practices in north west London. Br J Gen Pract (1992) 2.88
Survival of patients with a new diagnosis of heart failure: a population based study. Heart (2000) 2.86
Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Stat Med (2002) 2.86
Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med (2002) 2.73
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation (1997) 2.69
Management of angina pectoris in general practice: a questionnaire survey of general practitioners. Br J Gen Pract (1995) 2.64
Heart failure in a district general hospital. J R Coll Physicians Lond (1992) 2.61
A likelihood approach to meta-analysis with random effects. Stat Med (1996) 2.54
Sporulation in Bacillus subtilis. Correlation of biochemical events with morphological changes in asporogenous mutants. Biochem J (1970) 2.52
17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation (1995) 2.49
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation (2000) 2.49
Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. The British Family Heart Study. Arch Fam Med (1997) 2.41
Age at last full-term pregnancy and risk of breast cancer. Lancet (1993) 2.34
Streptococcal infection, Tourette syndrome, and OCD: is there a connection? Neurology (2009) 2.33
Analysis of clinical decision-making in multi-disciplinary cancer teams. Ann Oncol (2005) 2.31
Pathogenesis of edema in constrictive pericarditis. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones before and after pericardiectomy. Circulation (1991) 2.28
Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation (1998) 2.26
Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. Lancet (2003) 2.25
Incidence, clinical characteristics, and short-term prognosis of angina pectoris. Br Heart J (1995) 2.24
Hypothesis: inhibition of endothelium-derived relaxing factor by haemoglobin in the pathogenesis of pre-eclampsia. Lancet (1990) 2.24
Respiratory gas exchange in the assessment of patients with impaired ventricular function. Br Heart J (1985) 2.17
Analysis of a cluster randomized trial with binary outcome data using a multi-level model. Stat Med (2000) 2.14
Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J (Clin Res Ed) (1986) 2.09
Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol (1997) 2.08
Meta-analysis of continuous outcome data from individual patients. Stat Med (2001) 2.07
Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. Br Med J (1971) 2.06
A multilevel model framework for meta-analysis of clinical trials with binary outcomes. Stat Med (2000) 2.06
Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol (1997) 2.05
Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation (1993) 2.05
Fifteen-year follow-up of a randomized clinical trial of ultrasonographic screening for abdominal aortic aneurysms. Br J Surg (2007) 2.04
Should the frequency of surveillance for small abdominal aortic aneurysms be reduced? Eur J Vasc Endovasc Surg (2013) 2.04
The Lancet's statistical review process: areas for improvement by authors. Lancet (1992) 2.00
Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure. Br Heart J (1990) 2.00
Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J (1998) 1.97
The relation between treatment benefit and underlying risk in meta-analysis. BMJ (1996) 1.96
Hypoxia and calcium. J Mol Cell Cardiol (1979) 1.94
The natural course of alcoholic cardiomyopathy. Ann Intern Med (1974) 1.85
The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J (2004) 1.84
Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study. BMJ (2007) 1.81
C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation (2001) 1.81
Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation (1996) 1.80
The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J (1997) 1.80
Identification of two laccase genes in the cultivated mushroom Agaricus bisporus. J Gen Microbiol (1993) 1.76
Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol (1996) 1.76
Recommendations for transoesophageal echocardiography: update 2010. Eur J Echocardiogr (2010) 1.75
Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation (2001) 1.75
Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial. Eur Heart J (2004) 1.74
Exercise based rehabilitation for heart failure. Cochrane Database Syst Rev (2004) 1.70
Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form. Am J Epidemiol (1996) 1.70